First up, EuroNews, February 12:
Who are the GRANOLAS? A look at Europe's 'Magnificent Eleven' stocks
Goldman Sachs shines a light on Europe's market leaders, dubbed the 'GRANOLAS', echoing the 'Magnificent Seven' of Wall Street. With a combined market cap exceeding €2.6 trillion, these firms continue to dominate sectors and outperform in European markets.
Goldman Sachs has put a spotlight on Europe's stock market champions with a peculiar nickname: The GRANOLAS.
The tag was inspired by the US market's 'Magnificent Seven' – the tech behemoths leading Wall Street. It refers to a select group of European heavyweights, including GSK, Roche, ASML, Nestlé, Novartis, Novo Nordisk, L'Oréal, LVMH, AstraZeneca, SAP, and Sanofi.
These firms, with a towering combined market cap exceeding €2.6 trillion, have eclipsed the broader European stock market's performance in recent years....
....MUCH MORE
Meanwhile MarketWatch, via Morningstar points out:
This grouping of stocks has actually kept up with the Magnificent Seven, and with a lot less risk
Neither story tells us the Sharpe Ratios of the two portfolios but if I remember I will make inquiries.
